ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Case of Severe Neutropenia Resolved by Suspension of Sitagliptin Intake in a Patient Also Treated with Metformin

Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.6, No. 6)

Publication Date:

Authors : ; ; ; ; ;

Page : 18-20

Keywords : ;

Source : Download Find it from : Google Scholarexternal

Abstract

Neutropenia is a disorder characterized by a reduction in the absolute number of circulating neutrophils below age- and raceidentified normal limits. Sitagliptin is an oral antihyperglycemic agent licensed for the treatment of type 2 diabetes. The clinical case reviewed in this report involves leukopenia from severe neutropenia that resolved with discontinuation of sitagliptin therapy

Last modified: 2024-01-09 16:07:55